A Single-volunteer Study of Immune Response Following OTS-412 Vaccinia Virus Systemic Injection(Self-experiment)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
Following oncolytic virus (OV) administration, the host immune response is initiated immediately and evolves dynamically. However, in clinical OV therapy, it is virtually impossible to capture these immune events in real time. To address this gap, the principal investigator conducted a high-resolution immune monitoring study in a healthy volunteer.
Epistemonikos ID: c0952b7a8a94cf22db6c7644ee320a132675ce82
First added on: Dec 25, 2025